// App-Quantinova.ai

7534 : Impact of IgVH mutational status in patients with chronic lymphocytic leukemia with isolated good and intermidiate risk genetic aberrations.

Researchers

Presenter

  • Jose David Sandoval-Sus

Principal Investigators

  • Samir Dalia

  • Chetasi Talati

  • Bijal D. Shah

  • Celeste M. Bello

  • Jeffrey E. Lancet

  • Paul A. Chervenick

  • Frederick Lundry Locke

  • Mohamed Kharfan-Dabaja

  • Eduardo M. Sotomayor

  • Lubomir Sokol

  • Julio C. Chavez

  • Javier Pinilla-Ibarz

Medical Centers

  • Moffitt Cancer Center, Tampa, FL

  • Mercy Clinic Joplin, Joplin, MO

  • University of South Florida/Moffitt Cancer Center, Tampa, FL

  • H. Lee Moffitt Cancer Center & Research Institute, Riverview, FL

  • Moffitt Cancer Ctr Univ of S Florida, Tampa, FL

  • Georgetown University, Washington, DC

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Lymphocytic Leukemia

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final